{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:47:17Z","timestamp":1764251237248,"version":"3.37.3"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1097\/meg.0b013e3283329d13","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T09:08:27Z","timestamp":1268212107000},"page":"494-499","source":"Crossref","is-referenced-by-count":33,"title":["Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B"],"prefix":"10.1097","volume":"22","author":[{"given":"Xavier","family":"Verhelst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Orlent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Colle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Geerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Van Vlierberghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210207","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn's disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"R2-17-20210207","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumour necrosis factor trial in rheumatoid arthritis with concomitant therapy study group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"R3-17-20210207","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/ard.59.6.428","article-title":"Effects of loading dose regimen of three infusions of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) in spondylarthropathy: an open pilot study","volume":"59","author":"Van den Bosch","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"R4-17-20210207","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra032906","article-title":"New Drugs for rheumatoid arthritis","volume":"350","author":"Olsen","year":"2004","journal-title":"N Engl J Med"},{"key":"R5-17-20210207","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/art.11301","article-title":"Infections and anti-tumor necrosis factor alpha therapy","volume":"48","author":"Ellerin","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R6-17-20210207","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/rheumatology\/kep003","article-title":"Anti-TNF-\u03b1 therapy for rheumatoid arthritis among patients with chronic hepatitis B infection","volume":"48","author":"Robinson","year":"2009","journal-title":"Rheumatology"},{"key":"R8-17-20210207","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0016-5085(89)90081-4","article-title":"Early indicators of prognosis in fulminant hepatic failure","volume":"97","author":"O'Grady","year":"1989","journal-title":"Gastroenterology"},{"key":"R9-17-20210207","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/ard.2005.043257","article-title":"Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies","volume":"65","author":"Calabrese","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R10-17-20210207","first-page":"1624","article-title":"Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset Still's disease","volume":"30","author":"Michel","year":"2003","journal-title":"J Rheumatol"},{"key":"R11-17-20210207","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/ard.62.7.686","article-title":"Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate","volume":"62","author":"Ostuni","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R12-17-20210207","first-page":"107","article-title":"Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C","volume":"31","author":"Oniankitan","year":"2004","journal-title":"J Rheumatol"},{"issue":"2","key":"R13-17-20210207","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1136\/ard.2004.028209","article-title":"Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection","volume":"63","author":"Calabrese","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R14-17-20210207","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/gut.2004.040675","article-title":"Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis","volume":"53","author":"Esteve","year":"2004","journal-title":"Gut"},{"key":"R15-17-20210207","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10620-005-1295-8","article-title":"Infliximab therapy for Crohn's disease in a patient with chronic hepatitis B","volume":"50","author":"Ueno","year":"2005","journal-title":"Dig Dis Sci"},{"key":"R16-17-20210207","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1002\/art.21216","article-title":"Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab","volume":"52","author":"Anelli","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R17-17-20210207","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/rheumatology\/kel123","article-title":"Safety of anti-TNF-alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis","volume":"45","author":"Roux","year":"2006","journal-title":"Rheumatology"},{"key":"R18-17-20210207","first-page":"421","article-title":"Short-term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis","volume":"35","author":"Cansu","year":"2008","journal-title":"J Rheumatol"},{"key":"R19-17-20210207","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/ard.2004.031187","article-title":"Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy","volume":"64","author":"Wendling","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R20-17-20210207","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s10067-008-0896-y","article-title":"Histological evaluation of liver in two rheumatoid arthritis patients with chronic hepatitis B and C treated with TNF-alpha blockade: case reports","volume":"27","author":"Kaur","year":"2008","journal-title":"Clin Rheumatol"},{"key":"R21-17-20210207","doi-asserted-by":"crossref","first-page":"b508","DOI":"10.1136\/bmj.b508","article-title":"Life threatening liver disease during treatment with monoclonal antibodies","volume":"338","author":"Kaiser","year":"2009","journal-title":"BMJ"},{"key":"R22-17-20210207","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1053\/gast.2001.22461","article-title":"Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease","volume":"120","author":"Perillo","year":"2001","journal-title":"Gastroenterology"},{"key":"R23-17-20210207","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R24-17-20210207","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B","volume":"50","year":"2009","journal-title":"J Hepatol"},{"key":"R25-17-20210207","first-page":"389","article-title":"Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines","volume":"70","author":"Colle","year":"2007","journal-title":"Acta Gastroentero Belg"},{"key":"R26-17-20210207","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"AASLD practice guidelines. Chronic hepatitis B","volume":"45","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"R27-17-20210207","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1440-1746.2006.04559.x","article-title":"Hepatitis B and C virus infections and anti-tumor necrosis factor-\u03b1 therapy: guidelines for clinical approach","volume":"21","author":"Nathan","year":"2006","journal-title":"J Gastroenterol and Hepatol"},{"key":"R29-17-20210207","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/hep.21783","article-title":"Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: a decision model analysis","volume":"46","author":"Saab","year":"2007","journal-title":"Hepatology"},{"key":"R30-17-20210207","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3748\/wjg.v13.i1.125","article-title":"Antiviral therapy and resistance with hepatitis B virus infection","volume":"13","author":"Tillmann","year":"2007","journal-title":"World J Gastroenterol"},{"key":"R31-17-20210207","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/rmv.595","article-title":"Hepatitis B and liver transplantation: 2008 update","volume":"19","author":"Beckebaum","year":"2009","journal-title":"Rev Med Virol"},{"key":"R32-17-20210207","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","article-title":"Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for chronic hepatits B","volume":"23","author":"Marcellin","year":"2008","journal-title":"N Engl J Med"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0b013e3283329d13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:48:12Z","timestamp":1739962092000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042737-201004000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0b013e3283329d13","relation":{},"ISSN":["0954-691X"],"issn-type":[{"type":"print","value":"0954-691X"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}